Health In Tech (NASDAQ: HIT) CEO awarded 1M restricted shares in grant

Rhea-AI Filing Summary

Health In Tech, Inc. reported that Chief Executive Officer, director and 10% owner Tim Johnson received a grant of 1,000,000 restricted shares of Class A Common Stock on January 6, 2026 at a price of $0 per share under the Health In Tech Equity Incentive Plan. The grant is tied to two proposed issuer transactions: half of the shares vest in equal monthly installments over 12 months starting at the closing of the first transaction, and the other half vest monthly over 12 months starting at the closing of the second transaction, in each case subject to continued service.

If either transaction does not close within 24 months after January 6, 2026, any unvested shares relating to that transaction will be automatically forfeited without consideration. Following this award, Johnson beneficially owns 23,549,741 shares of Class A Common Stock, including 1,126,130 restricted shares and 22,423,611 unrestricted shares.

Insights

Equity compensation analyst

CEO receives 1,000,000 contingent RSs tied to two proposed deals.

The filing shows Health In Tech, Inc. granting CEO Tim Johnson 1,000,000 restricted shares of Class A Common Stock on January 6, 2026 at $0 per share under the company’s equity incentive plan. This is a stock-based compensation award rather than a cash transaction, and it is structured around two proposed issuer transactions, described as separate “Transactions.”

Half of the award vests in equal monthly installments over 12 months starting at the closing of the first Transaction, and the other half vests monthly over 12 months starting at the closing of the second Transaction, with vesting conditioned on continued service. The terms also state that if either Transaction does not close within 24 months after the Grant Date, any unvested shares tied to that Transaction are automatically forfeited without consideration, linking the realized value of the award to deal completion.

After this grant, Johnson beneficially owns 23,549,741 shares of Class A Common Stock, comprised of 1,126,130 restricted shares and 22,423,611 unrestricted shares. The award increases his equity stake but with vesting and forfeiture conditions that depend on both the closing of the proposed Transactions and his ongoing service, so the ultimate impact will follow future transaction and vesting outcomes disclosed in subsequent filings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Johnson Tim Donald

(Last) (First) (Middle)

701 S. COLORADO AVE,

SUITE 1

(Street)

STUART FL 34994

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	01/06/2026		A		1,000,000(1)	A	$0	23,549,741(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan in connection with two proposed issuer transactions (each, a "Transaction"). Half of the shares vest in equal monthly installments over 12 months starting at the closing of the first Transaction ("First Transaction Shares"). The other half vest in equal monthly installments over 12 months starting at the closing of the second Transaction ("Second Transaction Shares"). Vesting is subject to continued service. If either Transaction does not close within 24 months after January 6, 2026 (the "Grant Date"), unvested shares relating to that Transaction will be automatically forfeited without consideration.

2. Includes 1,126,130 shares of restricted shares of Class A Common Stock and 22,423,611 unrestricted shares of Class A Common Stock. Excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.

	/s/ Tim Johnson	01/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Health In Tech (HIT) report for Tim Johnson?

The company reported that Chief Executive Officer Tim Johnson received 1,000,000 restricted shares of Class A Common Stock on January 6, 2026 at a price of $0 per share under the Health In Tech Equity Incentive Plan.

How do the 1,000,000 restricted shares granted to Tim Johnson at Health In Tech vest?

Half of the 1,000,000 restricted shares vest in equal monthly installments over 12 months starting at the closing of the first proposed issuer transaction, and the other half vest monthly over 12 months starting at the closing of the second proposed issuer transaction, in each case subject to continued service.

What happens to Tim Johnson’s restricted shares if Health In Tech’s proposed transactions do not close?

If either proposed issuer transaction does not close within 24 months after January 6, 2026, any unvested restricted shares relating to that transaction will be automatically forfeited without consideration.

How many Health In Tech Class A shares does Tim Johnson own after this award?

Following the transaction, Tim Johnson beneficially owns 23,549,741 shares of Class A Common Stock, including 1,126,130 restricted shares and 22,423,611 unrestricted shares.

What roles does Tim Johnson hold at Health In Tech (HIT)?

Tim Johnson is reported as a director, Chief Executive Officer, and a 10% owner of Health In Tech, Inc.

Is Tim Johnson’s Health In Tech share ownership direct or indirect?

The filing shows Tim Johnson’s 23,549,741 shares of Class A Common Stock as directly owned, with no separate nature of indirect beneficial ownership listed.